Showing results (341-350 of 4,125) with videos related to
Sort By:
Pageof 413
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Benign hereditary chorea--entity or syndrome?A Schrag, N P Quinn, K P Bhatia, et al.British Journal of Clinical Pharmacology|January 6, 2012
Bromocriptine and dopamine receptor stimulationA G Debono, C D Marsden, P Asselman, et al.Brain : a Journal of Neurology|September 1, 1985
Pathophysiology of blepharospasm and oromandibular dystoniaA Berardelli, J C Rothwell, B L Day, et al.Annals of Neurology|January 1, 1992
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research GroupD T Dexter, P Jenner, A H Schapira, et al.Biochemical Pharmacology|May 11, 1995
Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviourK K Gnanalingham, A J Hunter, P Jenner, et al.Psychopharmacology|February 1, 1995
The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's diseaseK K Gnanalingham, A J Hunter, P Jenner, et al.The Journal of Pharmacy and Pharmacology|March 1, 1983
Hypophysectomy does not prevent increased cerebral dopamine turnover following sulpiride administrationL M Reynolds, R G Dyer, P Jenner, et al.Synapse (New York, N.Y.)|July 1, 1997
Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmosetG M Mackenzie, M J Jackson, P Jenner, et al.Neuroscience|January 1, 1984
A comparison of the effects of acute and one year's continuous neuroleptic treatment on the release of [3H]glutamate and [3H]acetylcholine from rat striatal slicesR W Kerwin, N M Rupniak, P Jenner, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1990
Nasogastric and intravenous infusions of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's diseaseR J Coleman, N P Quinn, M Traub, et al.Pageof 413